Quick Answer
LIXTE BIOTECHNOLOGY HOLDINGS, INC. reported Stockholders Equity of $9.66 million for fiscal year 2025.
LIXTE BIOTECHNOLOGY HOLDINGS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $9.66M | +1068.3% |
| 2024 | $827.2K | -79.3% |
| 2023 | $3.99M | -22.7% |
| 2022 | $5.17M | +7.8% |
| 2021 | $4.79M | -4.4% |
| 2020 | $5.01M | +105.9% |
| 2019 | $2.43M | -41.0% |
| 2018 | $4.13M | +314.6% |
| 2017 | $995.0K | +363.3% |
| 2016 | $214.8K | -31.2% |
| 2015 | $312.3K | +17.5% |
| 2014 | $265.9K | +12.5% |
| 2013 | $236.3K | -84.2% |
| 2012 | $1.49M | +1787.9% |
| 2011 | $79.0K | -95.4% |
| 2010 | $1.74M | +33.4% |
| 2009 | $1.30M | +502.1% |
| 2008 | -$323.5K | -185.8% |
| 2007 | $376.9K | -31.8% |
| 2006 | $552.6K | +3878.5% |
| 2005 | -$14.6K | — |
| 2005 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.91M | +259.4% | +654.0% |
| June 30, 2025 | $651.5K | -71.0% | -43.8% |
| March 31, 2025 | $1.16M | -62.9% | +40.1% |
| December 31, 2024 | $827.2K | -79.3% | -39.5% |
| September 30, 2024 | $1.37M | -72.2% | -39.1% |
| June 30, 2024 | $2.25M | -16.6% | -28.2% |
| March 31, 2024 | $3.13M | -23.4% | -21.7% |
| December 31, 2023 | $3.99M | -22.7% | -18.9% |
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. showed an increase of +1068.3% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from LIXTE BIOTECHNOLOGY HOLDINGS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: